You must be logged in to update your preferences.
Hotscan licences were needed for Sanctions look-ups introduced by new Operating Manuals for all First Line KYC and Due Diligence teams. However, Software, nor a new operating model were part of the Global Programme scope but a hard dependency on the regional BAU team to organise. Three weeks before Go Live and after Operating Manual...
The Telecoms client has grown quickly by acquisition, but had not harmonised the job roles or processes of the whole Service Management organsation, and hence their big global customers were receiving a patchy and confusing service, and were complaining.
The client, a large global financial institution was undertaking a transformation programme to significantly improve the performance of the IT Department. They were committed to moving to CMMI Level 3 within a 6 month period with an ambition to move to CMMI Level 5 within 2 years. There was additional requirement of ensuring the organisation...
The business needed to upgrade their Windows OS at the same time as reshaping customer processes through customer led design and introducing automation for some tasks.
The business needed to upgrade its core customer platform
The business did not have a communication, engagement and culture strategy. They were starting a period of transformation.
The business needed to reintegrate with the parent company, having started a journey to divestment.
The client selected a ‘Hard Brexit’ scenario and mobilised a programme to secure market access for clients in remaining EU27 countries. Two exstant EU entities in Madrid and Frankfurt would be repurposed to ensure business and revenue continuity.
The company needed to move from inefficient Excel reporting because it does not sufficiently support decision-making in a modern, data-driven organisation.
Mundipharma is the international division of US company Purdue Pharma, based in the UK, with presence across most of Europe, and annual revenues of €1 billion. Having specialised primarily in pain relief – benefitting from the global sales of the opioid Oxycontin and related products – Mundipharma had, several years prior to this project, begun...